Beam Therapeutics
BEAM
BEAM
193 hedge funds and large institutions have $2.05B invested in Beam Therapeutics in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 78 increasing their positions, 46 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
6% less funds holding
Funds holding: 205 → 193 (-12)
35% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 31
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
193
Holding in Top 10
1
Calls
$16M
Puts
$6.86M
Top Buyers
| 1 | +$33.8M | |
| 2 | +$33.5M | |
| 3 | +$19.9M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$17.8M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$17.8M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$6.36M | |
| 3 | -$6.09M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$6.08M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.02M |